ABL Bio, Immuno-oncology Theme Rises 29.98%

On the 10th, the immuno-oncology theme showed strength, rising 3.09% compared to the previous day, with ABL Bio, a related stock attracting attention, soaring 29.98% from the previous day.

[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme



According to provisional data compiled at 10:26, foreign investors have been buying 45,000 shares of ABL Bio, indicating a large net purchase by foreigners.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, ABL Bio’s quant financial score is 5.83 points, ranking 18th in the quant financial ranking within the immuno-oncology theme. This can be interpreted as ABL Bio having relatively low investment attractiveness from a financial perspective. On the other hand, Dong-A ST ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top Stocks by Financial Score within the Theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.